![]() |
|||||
|---|---|---|---|---|---|
| March 2026 Volume 24, Number 3 | |||||
This Just In ... New Guidance Issued on 2026 Pharmacy Benefit Transparency RulesFederal regulators have released new guidance clarifying the pharmacy benefit transparency requirements taking effect later this year. The rules aim to improve visibility into drug pricing and PBM practices by requiring group health plans to report detailed information on rebates, fees, and prescription drug spending.
The guidance outlines what information must be included in annual reports, how data should be categorized, and what documentation employers must maintain. It also clarifies expectations for plans that use third party administrators or PBMs to manage pharmacy benefits. Employers are encouraged to:
With reporting deadlines approaching, employers should ensure they have the systems and documentation needed to comply with the new rules. |
|
This Just In ... New Guidance Issued on 2026 Pharmacy Benefit Transparency Rules The 2026 Specialty Drug Surge: What Employers Need to Prepare For The New Era of Mental Health Parity Enforcement in 2026 The Return of Onsite and Near Site Clinics in 2026 Voluntary Benefits in 2026: Expanding Choice Without Raising Costs
|
|||
|
|||||